These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin. Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913 [TBL] [Abstract][Full Text] [Related]
3. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy? Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181 [TBL] [Abstract][Full Text] [Related]
4. Clinical Impact of Detectable Antithyroglobulin Antibodies Below the Reference Limit (Borderline) in Patients with Papillary Thyroid Carcinoma with Undetectable Serum Thyroglobulin and Normal Neck Ultrasonography After Ablation: A Prospective Study. Côrtes MCS; Rosario PW; Oliveira LFF; Calsolari MR Thyroid; 2018 Feb; 28(2):229-235. PubMed ID: 29325506 [TBL] [Abstract][Full Text] [Related]
5. Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobulin Unnecessary. Domínguez JM; Nilo F; Contreras T; Carmona R; Droppelmann N; González H; Iturrieta V; Tuttle RM J Ultrasound Med; 2017 Nov; 36(11):2299-2307. PubMed ID: 28543974 [TBL] [Abstract][Full Text] [Related]
6. Is stimulation of thyroglobulin (Tg) useful in low-risk patients with thyroid carcinoma and undetectable Tg on thyroxin and negative neck ultrasound? Rosário PW; Borges MA; Fagundes TA; Franco AC; Purisch S Clin Endocrinol (Oxf); 2005 Feb; 62(2):121-5. PubMed ID: 15670185 [TBL] [Abstract][Full Text] [Related]
7. Post-operative stimulated thyroglobulin and neck ultrasound as personalized criteria for risk stratification and radioactive iodine selection in low- and intermediate-risk papillary thyroid cancer. Orlov S; Salari F; Kashat L; Freeman JL; Vescan A; Witterick IJ; Walfish PG Endocrine; 2015 Sep; 50(1):130-7. PubMed ID: 25792004 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin. Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210 [TBL] [Abstract][Full Text] [Related]
9. Postoperative stimulated thyroglobulin of less than 1 ng/ml as a criterion to spare low-risk patients with papillary thyroid cancer from radioactive iodine ablation. Rosario PW; Mineiro Filho AF; Prates BS; Silva LC; Calsolari MR Thyroid; 2012 Nov; 22(11):1140-3. PubMed ID: 23050786 [TBL] [Abstract][Full Text] [Related]
10. Thyroid Ultrasound: More Sensitive than Radioactive Iodine Imaging in Detecting Recurrence of Papillary Thyroid Cancer in Two Pediatric Patients. Wise-Oringer BK; Goldis M; Regelmann MO; Klein M; Machac J; Kotlus Rosenberg H; Rapaport R Horm Res Paediatr; 2018; 90(1):66-72. PubMed ID: 29804120 [TBL] [Abstract][Full Text] [Related]
12. Individualized Follow-Up Strategy for Patients with an Indeterminate Response to Initial Therapy for Papillary Thyroid Carcinoma. Oh HS; Ahn JH; Song E; Han JM; Kim WG; Kim TY; Kim WB; Shong YK; Jeon MJ Thyroid; 2019 Feb; 29(2):209-215. PubMed ID: 30384812 [TBL] [Abstract][Full Text] [Related]
13. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment. Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265 [TBL] [Abstract][Full Text] [Related]
14. Changes in Serum Thyroglobulin Levels After Lobectomy in Patients with Low-Risk Papillary Thyroid Cancer. Park S; Jeon MJ; Oh HS; Lee YM; Sung TY; Han M; Han JM; Kim TY; Chung KW; Kim WB; Shong YK; Kim WG Thyroid; 2018 Aug; 28(8):997-1003. PubMed ID: 29845894 [TBL] [Abstract][Full Text] [Related]
15. Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy. Xing Z; Qiu Y; Li Z; Zhang L; Fei Y; Zhu J; Su A BMC Surg; 2021 Jan; 21(1):53. PubMed ID: 33482804 [TBL] [Abstract][Full Text] [Related]
16. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation. Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815 [TBL] [Abstract][Full Text] [Related]
17. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin? Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617 [TBL] [Abstract][Full Text] [Related]
18. Serum thyroglobulin level measured after thyroxine withdrawal is useful to predict further recurrence in whole body scan-negative papillary thyroid cancer patients after reoperation. Park DJ; Lim JA; Kim TH; Choi HS; Ahn HY; Lee EK; Lee YJ; Kim KW; Park YJ; Yi KH; Cho BY Endocr J; 2012; 59(11):1021-30. PubMed ID: 22814366 [TBL] [Abstract][Full Text] [Related]
19. Predictors of response to Radioactive Iodine Therapy in Intermediate and high risk patients with papillary thyroid carcinoma. Keshavarzi A; Alaei-Shahmiri F; Fallahi B; Emami Z; Malek M; Khamseh ME BMC Endocr Disord; 2024 Jul; 24(1):112. PubMed ID: 39004697 [TBL] [Abstract][Full Text] [Related]
20. Algorithm for safe and effective reoperative thyroid bed surgery for recurrent/persistent papillary thyroid carcinoma. Farrag TY; Agrawal N; Sheth S; Bettegowda C; Ewertz M; Kim M; Tufano RP Head Neck; 2007 Dec; 29(12):1069-74. PubMed ID: 17563908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]